Published Mar 08, 2024

Labshares Collaborates with Mispro and Charles River Accelerator and Development Lab (CRADL) to Create New Vivarium Partnerships

Shared lab space redefined: Explore Labshare's groundbreaking Vivarium Partnerships for cutting-edge research and collaborative innovation today
Labshares News
Exciting news at Labshares! We've partnered with Mispro and CRADL to enhance our shared lab spaces in Boston, offering members preferred pricing for top-notch research facilities.

We are thrilled to announce an exciting development at Labshares, your premier destination for shared laboratory space in the greater Boston area. Our commitment to collaboration has led us to create a partnership with two distinguished vivariums: Mispro and Charles River Accelerator and Development Lab. Labshares is supporting our members’ research efforts by providing cost-effective opportunities, through preferred pricing, when they utilize the Mispro and CRADL (Charles River Accelerator Development and Labs) vivariums.

Elevating Research Possibilities Through Collaboration

At Labshares, we recognize the pivotal role of collaboration in driving scientific progress. Our shared lab model has always been centered around building connections and facilitating interdisciplinary breakthroughs. Now, with the addition of the Mispro and CRADL vivariums to our network, we are creating new opportunities for collaboration and discovery.

Introducing Mispro

Mispro is known for its commitment to excellence in animal care and research support services. With state-of-the-art facilities and a dedicated team of experts, Mispro provides researchers with the resources they need to conduct preclinical studies and advance their scientific agendas.

From rodent models to large animal species, Mispro offers a comprehensive suite of services tailored to meet the diverse needs of the biomedical research community. With a focus on animal welfare and scientific integrity, Mispro is a trusted partner for researchers seeking to translate their discoveries into meaningful advancements in life sciences.

Exploring CRADL Vivarium

CRADL is one of the leaders of innovation in vivarium management and support services. With a commitment to excellence and a passion for advancing scientific knowledge, CRADL Vivarium offers a comprehensive range of vivarium solutions designed to meet the evolving needs of researchers and institutions.

From specialized housing solutions to personalized care protocols, CRADL delivers tailored services that empower researchers to conduct their studies with confidence and precision. With a team of experienced professionals and a focus on customer satisfaction, CRADL is dedicated to supporting the success of every research endeavor.

An Entrance to New Opportunities

Through collaboration with Mispro and CRADL, Labshares is introducing a new phase of innovation and collaboration in the life sciences. With this partnership, we are expanding the possibilities and maximizing the potential of the lab incubator model. Labshares is here to support you in preclinical research, therapeutic development, and biomedical exploration, serving as your trusted ally in achieving success.

Join Us

This partnership marks a significant step forward in enhancing the capabilities and resources available to researchers and entrepreneurs. Together, we aim to provide practical solutions and support that enable meaningful progress in scientific endeavors. As we move forward into this new chapter, we invite you to discover how our shared lab solution can be the right fit. Whether you are a seasoned researcher seeking state-of-the-art laboratory space, or an entrepreneur looking to make a difference, Labshares is your home for success.

Discover more about Labshares and explore our available lab space for rent today.

Related or similar articles

March 26, 2019

Abcuro announces pre-clinical data on new immuno-oncology target

First in vivo validation of KLRG1 as a new cancer immunotherapy target
Member News
August 19, 2019

Angel-Funded Siamab Completes $202 Million Exit with Large Commercial-Stage Biopharma

Siamab Therapeutics, Inc., a biopharmaceutical company developing novel glycan-targeted cancer therapeutics, has entered into a strategic agreement valued at up to $202 million with an undisclosed, large commercial-stage biopharmaceutical company ...
Member News
March 8, 2024

Labshares Collaborates with Mispro and Charles River Accelerator and Development Lab (CRADL) to Create New Vivarium Partnerships

Exciting news at Labshares! We've partnered with Mispro and CRADL to enhance our shared lab spaces in Boston, offering members preferred pricing for top-notch research facilities.
Labshares News